The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
Clinical Relevance of Invasion Factors Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 for Individualized Therapy Decisions in Primary Breast Cancer Is Greatest When ...
Background: Disparities in mortality in prostate cancer may reflect differences in healthcare providers’ communication. Objective: This study examined physicians’ communication with African American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback